Access cutting-edge rhabdoid tumor treatment through this clinical trial at a research site in Houston. Study-provided care at no cost to qualified participants.
Access rhabdoid tumor specialists in Houston at no cost
This study follows strict safety protocols and ethical guidelines
All study-related rhabdoid tumor treatment provided free
This research study involves a combination of three drugs given together as a possible treatment for malignant rhabdoid tumor, atypical teratoid rhabdoid tumor, epithelioid sarcoma, chordoma or other tumors that are deficient in one of two possible proteins, either INI-1 (SMARCB1) or SMARCA4. The names of the study drugs involved in this study are: * Tazemetostat (TAZVERIK) * Nivolumab (OPDIVO) * Ipilimumab (YERVOY)
Sponsor: Susan Chi, MD
Check if you qualify for this rhabdoid tumor clinical trial in Houston, TX
If you're searching for rhabdoid tumor treatment options in Houston, TX, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Houston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced rhabdoid tumor specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.